Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05305794

Recruitment Status : Active, not recruiting

First Posted : March 31, 2022

Last Update Posted : May 3, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Centre Hospitalier Universitaire Dijon

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	August 2026
Estimated Study Completion Date :	August 2026

To Top